HSP reduced the growth of MDA-MB-231 breast cancer cells by inhibiting HER2-tyrosine Kinase (HER2-TK) activity, causing MMP loss, chromatin condensation, and activating of caspase-8 and-3 [148]. The gene discussed is ERBB2; the disease is breast carcinoma.